[BRNS] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[BRNS] Barinthus Biotherapeutics plc
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 504.51%
YoY- 198.53%
Quarter Report
BRNS's Result
BRNS's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 334 17,063 35 511 -
PBT -17,663 -24,960 14,774 -15,973 -3,657 48.20%
Tax -701 -1,136 -915 12 610 -
NP -16,950 -23,802 15,693 -15,927 -3,588 47.38%
Tax Rate - - 6.19% - - -
Total Cost 16,950 24,136 1,370 15,962 4,099 42.56%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 -7,126.35 91.97 -45,505.71 -702.15 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.43 -0.62 0.42 -0.64 -75.31 -72.48%
EPS Diluted -0.43 -0.62 0.41 -0.64 -75.31 -72.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.